WellSync
WellSync is a private digital healthcare aggregator providing white-labeled, API-driven virtual care platforms to pharmacies, retailers, and direct-to-consumer companies. Its BoomRx subsidiary serves 4,500+ clinics across all 50 states, processing 40,000+ prescriptions monthly.
- Company typePrivate
- Founded2022
- HeadquartersTampa, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What WellSync does
WellSync (legally Click to Fill, Inc.) is a private, Tampa-based digital healthcare aggregator founded in 2022 that sells white-labeled, API-driven virtual care infrastructure to pharmacies, retailers, direct-to-consumer companies, large employers, labs, and healthcare innovators. The platform enables partners to deploy branded telehealth experiences — including synchronous video consultations and asynchronous questionnaire-based care reviewed by clinicians in under two minutes — without building underlying technology themselves. Supporting capabilities span remote patient monitoring, lab testing integration, branded pharmacy discount programs, and integrated fulfillment through URAC-accredited partner pharmacies.
The company's core technology layer is complemented by a consumer-facing brand portfolio including InstaCare (acute care at $25 per visit), the WellSync Weight Loss GLP-1 program ($229-$1,399/month), Whole Health Rx (powered for The Vitamin Shoppe), and In-Store Virtual Clinics (QR-code kiosks deployed at Publix). In July 2025, WellSync launched BoomRx as a national pharmaceutical technology subsidiary, which has scaled to serve more than 4,500 clinics across all 50 states and process over 40,000 prescription orders per month at a 20% month-over-month growth rate and 85% clinic return rate, reaching a $70M+ annualized run rate by June 2026.
The business operates on a cash-pay model with revenue generated from per-visit consultation fees, recurring GLP-1 subscriptions, B2B platform licensing to enterprise partners, and pharmacy fulfillment transaction fees. Distribution combines direct enterprise sales (Publix, Meijer, The Vitamin Shoppe, GenoPalate, Marius Pharmaceuticals) with self-serve D2C channels and embedded white-label deployment into partner websites and apps. The company is founder-led by CEO Clint House and President/CMO/Founder Edward O'Bryan, MD, with 11-50 employees and no disclosed institutional funding.
WellSync firmographics
Firmographics- Name
- WellSync
- Legal name
- Click to Fill, Inc.
- Website
- https://wellsync.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- WellSync is a private digital healthcare aggregator providing white-labeled, API-driven virtual care platforms to pharmacies, retailers, and direct-to-consumer companies. Its BoomRx subsidiary serves 4,500+ clinics across all 50 states, processing 40,000+ prescriptions monthly.
- Ownership category
- akta.pro rank
WellSync industry classification
Industry- Product category
- Digital Health / Virtual Care Platform
- NAICS
- Other Ambulatory Health Care Services (6219), Pharmacies and Drug Retailers (45611), Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Retail-Drug Stores And Proprietary Stores (5912)
- akta.pro primary industry
- Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)
- akta.pro secondary industries
- DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA), Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing (HLALAIAH), Telepharmacy & Prescription Fulfillment Marketplaces (HLALALAF)
Keywords
Where WellSync is headquartered
LocationHeadquarters
- HQ city
- Tampa
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
WellSync business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Per-Visit Consultation Fees: WellSync charges per-visit fees for telehealth consultations ranging from $25-$99 depending on service type and complexity, including general consultations, HRT, and specialty services.
- Subscription/Recurring Programs: GLP-1 weight loss programs and ongoing medication management services generate recurring subscription revenue through monthly or ongoing treatment programs.
- Platform Licensing (B2B): White-label platform deployment to enterprise partners generates licensing and service fees from pharmacies, retailers, D2C companies, and healthcare organizations seeking to embed virtual care capabilities.
- Pharmacy Fulfillment: Mail order and retail pharmacy fulfillment services including prescription processing and medication delivery, with BoomRx subsidiary processing over 40,000 orders per month.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | InstaCare General Consultations - $25 per visit |
| Unit Pricing | Pay-as-you-go | Meijer Virtual Care Partnership - $29.99 per visit |
| Unit Pricing | Pay-as-you-go | Hormone Replacement Therapy (HRT) - $99 per 30-day cycle |
| Subscription | Monthly | Compound GLP-1 Medications - $229-$329 monthly |
| Subscription | Monthly | Brand-name GLP-1 Medications - $1,299-$1,399 monthly |
| Unit Pricing | Pay-as-you-go | In-store Virtual Clinic - $25 per visit |
Go-to-market motion3 records
Distribution channels8 records
Marketing channels8 records
WellSync product offering
Product offeringCore offering
WellSync operates as an agnostic digital healthcare aggregator providing a white-labeled, API-driven virtual care platform that enables pharmacies, retailers, D2C companies, employers, and labs to deploy synchronous and asynchronous telemedicine, prescription management, pharmacy fulfillment, lab testing, and remote patient monitoring under their own brands. The company sells the platform via B2B licensing to enterprise partners and additionally offers direct-to-consumer telehealth services including InstaCare acute consultations starting at $25/visit, GLP-1 weight loss subscriptions ($229-$1,399/month), HRT, and branded pharmacy discount cards.
Product overview
WellSync offers a modular virtual-first healthcare platform architecture comprising a white-labeled B2B core platform with multiple patient-facing interfaces and specialized product lines. The core WellSync Virtual-First Care Platform serves as the foundational infrastructure for B2B partners (pharmacies, retailers, DTC companies, employers), while the Care Hub (hub.wellsync.com) and InstaCare (care.wellsync.com) provide consumer-facing access points. Specialized verticals include BoomRx (pharmaceutical technology subsidiary launched July 2025, exceeding $70M annualized run rate), WellSync Weight Loss (GLP-1 program at weightloss.wellsync.com), and In-Store Virtual Clinics (retail QR-code kiosks). Supporting modules include Remote Patient Monitoring, Lab Testing & Diagnostics, Mail Order and Retail Pharmacy Fulfillment, Branded Pharmacy Discount Programs, Nutritional Supplementation, and the Rx Savings Card. The platform operates an asynchronous care model using questionnaire-based assessments reviewed by clinicians, with pricing from $25/visit for standard care to $1,399/month for weight loss medications.
Differentiator
Problem solved
Functional benefit
Brands
- BoomRx: National pharmaceutical technology platform providing prescription management services, processing over 40,000 orders per month across 4,500+ clinics in all 50 states.
- WellSync GLP1
- Whole Health Rx
Products and services
- WellSync Virtual-First Care Platform White-labeled, end-to-end virtual-first healthcare platform that enables pharmacies, direct-to-consumer companies, labs, large employers, and healthcare innovators to deliver scalable virtual care experiences including telemedicine, pharmacy fulfillment, RPM, and lab integration.
- BoomRx National pharmaceutical technology platform and WellSync subsidiary offering prescription-management services to clinics across all 50 states.
- InstaCare Acute care telehealth service offering treatment for common conditions (allergies, sinus infections, flu, headaches) at $25 per visit using asynchronous questionnaire-based assessments reviewed by clinicians within one hour.
- WellSync Weight Loss (GLP-1 Program) Weight loss subscription program offering GLP-1 medications including compounded semaglutide and tirzepatide (oral and injection) plus brand-name Ozempic and Mounjaro, with pricing from $229-$1,399/month.
- In-Store Virtual Clinics Retail-integrated virtual care kiosks deployed via QR code at partner retail locations enabling on-site medical consultations, diagnosis, prescriptions, and health products for $25 per visit.
- WellSync Rx Savings Card Free prescription discount card offering savings up to 80% on medications across participating pharmacies.
- Care Hub Patient-facing care platform offering asynchronous care for 35+ conditions across General Health, Men's Health, Women's Health, Sexual Health, Skin and Hair, and Medication Refills starting at $25 per visit.
- Hormone Replacement Therapy (HRT) Program Virtual HRT program offering Bi-est Cream, Estradiol Cream, and Estradiol Pills at $99 per 30-day supply via asynchronous consultations.
Quantifiable outcome
- BoomRx subsidiary exceeded $70M annualized run rate, serving 4,500+ clinics with 85% clinic return rate and 20% month-over-month growth
- +3 more outcomes
Companies that use WellSync
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles3 records
WellSync technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability2 records
Feature6 records
WellSync partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and strategic.
- MeijercoreMeijer partnership launched January 2026 offering virtual healthcare services to Meijer customers across the Midwest. Service costs $29.99/visit, requires no insurance, provides treatment for cold, flu, allergies, and hair loss through Meijer's website, pharmacy app, or text 'Care' to 75049. Partnership aims to remove healthcare access barriers for customers with busy schedules or transportation challenges.
- GenoPalatestrategicPartnership integrating WellSync's clinical care and GLP-1 prescription access with GenoPalate's personalized nutrition platform. GenoPalate's platform combines DNA, lifestyle, diet, and blood biomarkers with expert coaching for weight management, menopause, and longevity programs.
- Marius PharmaceuticalsstrategicWellSync collaborated with Marius Pharmaceuticals to offer KYZATREX (testosterone undecanoate) oral TRT on WellSync's virtual care platform. WellSync handles the complete patient journey from lab services pre-qualifying patients to virtual consultations, personalized treatment plans, and medication fulfillment shipped via URAC-accredited partner pharmacy.
- PublixcoreWellSync launched in-store virtual clinics at Publix locations enabling customers to access medical consultations via QR code scanning for $25/visit. Deployed across Publix's network of over 1,300 stores in the Southeast United States, offering diagnosis, prescriptions, and health products on-site.
- The Vitamin ShoppecoreThe Vitamin Shoppe launched Whole Health Rx, a virtual care platform powered by WellSync focusing on weight-management solutions. Partnership expanded in September 2024 to include testosterone replacement therapy (KYZATREX) within the Whole Health Rx telehealth platform.
- BoomRxcoreBoomRx is WellSync's national pharmaceutical technology platform subsidiary that has exceeded $70M annualized run rate since launching July 2025. Platform serves 4,500+ clinics across all 50 states, processing 40,000+ orders/month with 20% MoM growth and 85% clinic return rate.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
WellSync competitors and assessment
Company assessmentDirect peers
- Truepill: Pharmacy fulfillment and telehealth infrastructure provider powering DTC health brands — operates the same B2B white-label layer that BoomRx delivers within WellSync's stack.
- Hims & Hers Health: Public DTC telehealth company offering prescription-based care across men's health, women's health, weight loss (GLP-1s), and acute conditions on a cash-pay model — the most direct competitor to WellSync's condition-specific Rx and white-label platform thesis.
- Thirty Madison: Multi-brand virtual care company (Keeps, Nurx, Cove, etc.) operating condition-specific DTC clinics with cash-pay and pharmacy components — closely comparable to WellSync's condition-by-condition Rx approach.
- Ro: DTC telehealth platform offering condition-specific prescription programs (weight loss, men's health, fertility, dermatology) with pharmacy fulfillment infrastructure — overlaps directly with WellSync's consumer cash-pay clinics and Rx management stack.
- K Health: AI-driven virtual primary care platform offering condition-specific consultations and prescription treatments, increasingly including weight management — comparable to WellSync's asynchronous, low-friction care model.
- Sesame: Cash-pay telehealth marketplace offering $25+ visits across acute and chronic conditions, with prescription fulfillment — overlaps directly with WellSync's InstaCare price point and consumer funnel.
Broad incumbents
- Amazon One Medical: Amazon's consumer virtual care and primary care service combining on-demand telehealth with in-person clinics and pharmacy — a well-capitalized incumbent competing for the same cash-pay and employer-sponsored segments.
- LillyDirect: Eli Lilly's direct-to-patient platform offering branded Zepbound and other medications with telehealth and pharmacy integration — a pharma-sponsored distribution channel that competes with WellSync's GLP-1 subscription business.
- Teladoc Health: Largest publicly traded telehealth incumbent offering broad virtual care across primary care, chronic condition management, and mental health — represents the enterprise/insurance-integrated alternative to WellSync's cash-pay, white-label model.
Emerging players
- Midi Health: Specialty telehealth platform focused on women's midlife and hormonal health, including HRT — directly overlaps with WellSync's HRT and women's health condition modules.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
WellSync social profiles
Digital presenceWellSync compliance and trust
Trust signalCompliance4 records
WellSync financial estimates
Financial estimateRevenue estimate
Valuation estimate
WellSync leadership team
Management profileNumber of profiles
Profiles3 records
WellSync subsidiaries and ownership
Company hierarchySubsidiaries1 record
WellSync funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
WellSync M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about WellSync
What does WellSync do?
WellSync operates as an agnostic digital healthcare aggregator providing a white-labeled, API-driven virtual care platform that enables pharmacies, retailers, D2C companies, employers, and labs to deploy synchronous and asynchronous telemedicine, prescription management, pharmacy fulfillment, lab testing, and remote patient monitoring under their own brands. The company sells the platform via B2B licensing to enterprise partners and additionally offers direct-to-consumer telehealth services including InstaCare acute consultations starting at $25/visit, GLP-1 weight loss subscriptions ($229-$1,399/month), HRT, and branded pharmacy discount cards.
Is WellSync a public or private company?
WellSync is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was WellSync founded?
WellSync was founded in 2022. It employs 11 to 50 people.
Where is WellSync based?
WellSync is headquartered in Tampa, United States, in the North America region.
How does WellSync make money?
Four revenue lines are on record. Per-Visit Consultation Fees are the primary driver. The others are subscription/Recurring Programs, platform Licensing (B2B) and pharmacy Fulfillment.
Who are WellSync's main competitors?
Direct peers on record are Truepill, Hims & Hers Health, Thirty Madison, Ro, K Health and Sesame. Broad incumbents are Amazon One Medical, LillyDirect and Teladoc Health. Midi Health is listed as an emerging player.
Does WellSync have an API?
Yes. WellSync offers API-driven white-labeled healthcare technology that enables partners to integrate virtual care capabilities into their platforms. Features include synchronous and asynchronous telemedicine solutions, branded pharmacy discount programs, mail order pharmacy fulfillment, retail pharmacy integration, remote patient monitoring, lab testing integration, and provider network connectivity. Partners can deploy customizable, easy-to-use virtual care platforms that can be plugged into existing websites within days. The API supports connectivity for healthcare data exchange and patient care coordination.
What industry is WellSync in?
WellSync's product category is Digital Health / Virtual Care Platform. Its primary akta.pro industry code is HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs), with a secondary code of HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription). Its NAICS code is 6219 and its SIC code is 8000.